comparemela.com

Latest Breaking News On - Basilea pharmaceutica ag stock exchange - Page 1 : comparemela.com

Continued strong Cresemba® (isavuconazole) sales by Pfizer trigger USD 26 million sales milestone payments to Basilea

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, June 08, 2023 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the. | June 8, 2023

Switzerland generalBasel stadtUnited statesNils schrDavid veitchAsia pacificSwiss exchangeBasilea pharmaceutica international ltdHead of corporate communications investor relationsEuropean unionBasilea pharmaceutica ltdPharmaceutica ltdChief executive officerCorporate communicationsPharmaceutica international ltdPublic assessment report

Basilea Pharmaceutica : Minutes_EN | MarketScreener

English translation of the German original minutes Minutes of the 22nd Annual General Meeting of Basilea Pharmaceutica Ltd , held on April. | May 4, 2023

Domenico scalaStevend skolskyDamian hellerCaroline cronMartin nicklassonThomas wernerPeter ulliDaniel anlikerDavid veitchLeonard kruimerYves ackermannAndrea schmutzMeeting of basilea pharmaceutica ltdPricewaterhousecoopers ltdAnnual general meetingBasilea pharmaceutica ltd

Basilea Pharmaceutica : Updated March 31, 2023

Table of contents  Executive summary  Portfolio . | March 31, 2023

Switzerland generalBasilea pharmaceutica international ltdSwiss stock exchangeStock exchangeBasilea pharmaceutica ag stock exchangePress releaseXecutive bsln ch0011432447

Basilea announces transition milestone for oncology asset BAL0891, triggering milestone payment of USD 4 million by SillaJen

Basel/Allschwil, Switzerland, December 19, 2022 Basilea Pharmaceutica Ltd. , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial. | December 19, 2022

Basel stadtBasel allschwilNils schrMarc engelhardtBasilea pharmaceutica international ltdHead of corporate communications investor relationsSillajen incSwiss exchangeBasilea pharmaceutica ltdChief medical officerPharmaceutica ltdCorporate communicationsPharmaceutica international ltdBasilea pharmaceutica ag stock exchangePress releaseEvere bsln ch0011432447

Continued strong Cresemba® (isavuconazole) sales by Pfizer trigger USD 10 million sales milestone payment to Basilea

Ad hoc announcement pursuant to Art. 53 LR Basel, Switzerland, December 08, 2021 Basilea Pharmaceutica Ltd. , a commercial-stage biopharmaceutical company committed to meeting the needs of patients. | December 8, 2021

United statesHong kongBasel stadtMacau generalNils schrDavid veitchEuropean unionCorporate communications investor relationsBasilea pharmaceutica ltdSwiss exchangeGlobenewswire incChief executive officerPublic assessment reportBasilea pharmaceutica ag stock exchangePress releaseF bsln ch0011432447

vimarsana © 2020. All Rights Reserved.